Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. red blood cells
Show results for

Companies


Refine by

Red Blood Cells Articles & Analysis

29 news found

CD BioGlyco Now Provides Comprehensive Lectin Products for Glycobiology Research

CD BioGlyco Now Provides Comprehensive Lectin Products for Glycobiology Research

It is named lectin because it can agglutinate red blood cells (including blood group substances). Commonly used is Phytoagglutin (PNA), which is usually named after the plant from which it is extracted, such as Conconvalina (ConA), Wheat germ agglutinin (WGA), Peanut agglutinin (Peanut agglutinin, PNA) and soybean lectin (Soybean ...

ByCD BioGlyco.


MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024

MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024

About Myelofibrosis Myelofibrosis is a type of bone marrow cancer that causes extensive scarring in the bone marrow, which disrupts the body’s normal production of healthy blood cells. The result is a reduction in red blood cells, which can cause weakness and fatigue, and in platelets, which increases the ...

ByMorphoSys AG


MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

About Myelofibrosis Myelofibrosis is a type of bone marrow cancer that causes extensive scarring in the bone marrow, which disrupts the body’s normal production of healthy blood cells. The result is a reduction in red blood cells, which can cause weakness and fatigue, and in platelets, which increases the ...

ByMorphoSys AG


Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting

Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting

Miller also highlighted the importance of knowing the red blood cell volume to optimize fluid management which is a key metric of Daxor’s BVA-100 blood test, which he has utilized to publish more than a dozen peer-reviewed papers in leading journals. ...

ByDaxor Corporation


BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen

BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen

For pregnant patients who are alloimmunized with C, c, D, E, Duffy (Fya), or Kell (K) red blood cell (RBC) antibodies, this novel NIPT looks for the presence of the genetic variants that code for the corresponding fetal antigens. ...

ByBillionToOne Inc.


980nm diode laser for vascular removal

980nm diode laser for vascular removal

It can thermally coagulate hemoglobin in dilated capillaries and endothelial cells in capillaries within milliseconds, thereby sealing the dilated blood vessels immediately. Treatment Features 1. 980nm laser can promote collagen production, improve skin elasticity, and increase skin thickness and density. 2. 980nm laser repairs capillaries, restores the ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


CD Bioparticles Expands Lipid System Portfolio by the Launch of Sphingolipids

CD Bioparticles Expands Lipid System Portfolio by the Launch of Sphingolipids

CD Bioparticles now offers various options for researchers in Sphingomyelin, for example, the N-acetyl-D-erythro-sphingosylphosphorylcholine (Catalog: CDLP-A1144). As a major constituent of cell membranes, sphingomyelin is found at particularly high concentrations in the membranes of nerve cells (in myelin sheaths) and red blood ...

ByCD Bioparticles


Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

At one year, the overall survival without allogeneic hematopoietic stem cell transplantation across the cohort is 100% based on the Kaplan-Meier estimate. ...

ByRocket Pharmaceuticals, Inc.


New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device

New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device

” The study titled, “Intravascular Volume Derangement and Value of Blood Volume Analysis In Stable Ambulatory Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device,” described variations in blood volume status (total blood and red blood cell volume) ...

ByDaxor Corporation


Emmaus Life Sciences Announces Launch of Full-Service Telehealth Solution

Emmaus Life Sciences Announces Launch of Full-Service Telehealth Solution

The sickle gene is found in every ethnic group, not just among those of African descent; and in the United States an estimated 1-in-365 African Americans and 1-in-16,300 Hispanic Americans are born with SCD.1 The genetic mutation responsible for SCD causes an individual's red blood cells to distort into a "C" or a sickle shape, reducing their ...

ByEmmaus Medical, Inc


UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients

UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients

JELMYTO can affect your bone marrow and can cause a decrease in your white blood cell, red blood cell, and platelet counts. Your healthcare provider will do blood tests prior to each treatment to check your blood cell counts during treatment with JELMYTO. ...

ByUroGen Pharma, Inc.


Daxor Announces Key Milestones Achieved for Multicenter Bva-100® Study In Hospitalized Patients With Covid-19

Daxor Announces Key Milestones Achieved for Multicenter Bva-100® Study In Hospitalized Patients With Covid-19

The study, titled “Blood volume and albumin transudation in critically-ill COVID-19 patients,” showed that COVID-19 patients suffer from significant capillary damage and blood volume deficits that care teams became aware of only through the use of the Daxor BVA-100 blood test. ...

ByDaxor Corporation


Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19

Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19

“With patient enrollment complete and data analysis underway, we aim to show that the implications of COVID as an endothelial disease utilizing this measure along with precise measurement of total blood, red cell and plasma volume could help guide the care of COVID-19 patients, thus promoting better treatment of these ...

ByDaxor Corporation


Bilix, containing the identity of reverse thinking and novelty

Bilix, containing the identity of reverse thinking and novelty

Bilirubin is a yellow-brown substance present in bile and is a product produced when hemoglobin, a component of red blood cells, is metabolized when worn-out red blood cells are decomposed. ...

ByBilix Co., Ltd.


[IB Tomato] (VC Portfolio) Villix, Containing the Identity of Reverse Idea and Novelty

[IB Tomato] (VC Portfolio) Villix, Containing the Identity of Reverse Idea and Novelty

Bilirubin is a yellowish-brown substance present in bile that is produced when hemoglobin, a component of red blood cells, is metabolized when red blood cells that have reached the end of their life are decomposed. ...

ByBilix Co., Ltd.


Daxor Corporation Presents New Data Validating the Benefit of the BVA-100 Blood Test for Optimal Heart Failure Management at Key Scientific Society Meeting

Daxor Corporation Presents New Data Validating the Benefit of the BVA-100 Blood Test for Optimal Heart Failure Management at Key Scientific Society Meeting

” In heart failure, physicians seek to optimize a patient’s blood volume which has wide variations in total blood volume (TBV), plasma volume (PV) and red blood cell volume (RBCV). ...

ByDaxor Corporation


Emmaus Life Sciences Announces Partnership with UpScript to Provide Telehealth Solutions to Sickle Cell Disease Patients

Emmaus Life Sciences Announces Partnership with UpScript to Provide Telehealth Solutions to Sickle Cell Disease Patients

The sickle gene is found in every ethnic group, not just among those of African descent; and in the United States an estimated 1-in-365 African Americans and 1-in-16,300 Hispanic Americans are born with SCD.1 The genetic mutation responsible for SCD causes an individual’s red blood cells to distort into a “C” or a sickle shape, ...

ByEmmaus Medical, Inc


Alfa Chemistry—Reliable Supplier of Custom Synthesis of Functional Polymers

Alfa Chemistry—Reliable Supplier of Custom Synthesis of Functional Polymers

These include organic catalysis (supported catalysts), medicine (red-blood-cell substitutes), optoelectronics (conducting polymers, magnetic polymers and polymers for nonlinear optics), biomaterials, paints and varnishes, building materials, photographic materials as well as lube and fuel additives. ...

ByAlfa Chemistry


Health & Wellness: What Urinalysis Could Say About Your Well-being

Health & Wellness: What Urinalysis Could Say About Your Well-being

Gross and Chemical Exams include: Urine appearance and color Bilirubin Urobilinogen Glucose Hemoglobin Ketones Nitrite Urine pH Urine protein Specific gravity Microscopic Exams include: Bacteria and other microorganisms Casts Crystals Fat Mucus Red Blood Cells The most common procedure is the dipstick, a chemical exam ...

ByFluxergy


FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial

FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial

A single dose of AVM0703 triggers the rapid activation and mobilization of novel gamma delta positive Natural Killer T (NKT) cells. NKT cells exhibit properties of both innate and adaptive immunity. AVM-NKT cells home to abnormal cells including cancer and autoreactive lymphocytes sparing platelets, red ...

ByAVM Biotechnology

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT